Paper893247
Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
Neu HC. J Antimicrob Chemother, 1977. Cited by 52 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds. Papers, record 893247. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/893247
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Bacteria | Major topic |
| Penicillins | Major topic |
| beta-Lactams | Major topic |
| Aminoglycosides | |
| Amoxicillin | |
| Ampicillin | |
| Carbenicillin | |
| Cephalosporins | |
| Culture Media | |
| Drug Synergism | |
| Electric Conductivity | |
| Microbial Sensitivity Tests | |
| Osmolar Concentration | |
| Penicillin G |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,164,349 | Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model. | Molecules | 2022 | https://conductscience.org/library/papers/35164349 | PubMed |
| 24,069,959 | The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. | BMC Microbiol | 2013 | https://conductscience.org/library/papers/24069959 | PubMed |
| 7,811,027 | In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7811027 | PubMed |
| 6,284,652 | Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis. | Infection | 1982 | https://conductscience.org/library/papers/6284652 | PubMed |
| 6,277,795 | Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter. | Infection | 1981 | https://conductscience.org/library/papers/6277795 | PubMed |
| 6,264,850 | Mecillinam susceptibility of Escherichia coli K-12 mutants deficient in the adenosine 3',5'-monophosphate system. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6264850 | PubMed |
| 6,246,006 | Mecillinam and ampicillin separately or combined in gram-negative septicemia. | Infection | 1980 | https://conductscience.org/library/papers/6246006 | PubMed |
| 3,711,289 | Critical evaluation of amdinocillin disk susceptibility tests correlated with agar dilution tests. | J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3711289 | PubMed |
| 3,435,100 | Method of evaluating effects of antibiotics on bacterial biofilm. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3435100 | PubMed |
| 1,389,936 | The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women. | Br J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1389936 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/893247
GET https://conductscience.org/api/papers/v1/893247/authors